Ativo Capital Management’s Amgen AMGN Stock Holding History

Ativo Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,617	Closed	-$880K	–	61
2022 Q2	$880K	Hold	3,617	–	–	0.59%	100
2022 Q1	$875K	Sell	3,617 -128	-3%	-$29.4K	0.45%	108
2021 Q4	$843K	Hold	3,745	–	–	0.37%	107
2021 Q3	$796K	Buy	3,745 +139	+4%	+$32K	0.37%	107
2021 Q2	$879K	Hold	3,606	–	–	0.37%	107
2021 Q1	$897K	Sell	3,606 -498	-12%	-$119K	0.38%	109
2020 Q4	$944K	Sell	4,104 -2	-0%	-$461	0.41%	102
2020 Q3	$1.04M	Sell	4,106 -499	-11%	-$124K	0.5%	80
2020 Q2	$1.09M	Buy	4,605 +500	+12%	+$114K	0.59%	69
2020 Q1	$832K	Sell	4,105 -1,240	-23%	-$271K	0.52%	77
2019 Q4	$1.29M	Sell	5,345 -50	-0.9%	-$11K	0.59%	61
2019 Q3	$1.04M	Sell	5,395 -23	-0.4%	-$4.42K	0.51%	80
2019 Q2	$998K	Sell	5,418 -1,295	-19%	-$232K	0.45%	86
2019 Q1	$1.27M	Buy	6,713 +1	+0%	+$191	0.54%	73
2018 Q4	$1.31M	Sell	6,712 -1,700	-20%	-$332K	0.61%	54
2018 Q3	$1.74M	Sell	8,412 -54	-0.6%	-$10.6K	0.47%	57
2018 Q2	$1.56M	Hold	8,466	–	–	0.44%	55
2018 Q1	$1.44M	Buy	+8,466	New	+$1.55M	0.41%	82

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ativo Capital Management's AMGN Position: Q3 2022 in Review

Ativo Capital Management sold out of Amgen (AMGN) in Q3 2022, closing a stake of 3,617 shares — an estimated $880K sold.

Ativo Capital Management first reported a position in AMGN in Q1 2018 and held it in 18 quarters. The position peaked at $1.74M in Q3 2018. 2,322 funds tracked by Wall St. Rank hold AMGN as of Q3 2022.

Ativo Capital Management reported no remaining Amgen position as of Q3 2022 after selling out during the quarter.
Ativo Capital Management sold 3,617 Amgen shares in Q3 2022, an estimated $880K.
Ativo Capital Management first reported a position in Amgen in Q1 2018 and held it in 18 quarters.
Ativo Capital Management's Amgen position peaked at $1.74M in Q3 2018.
2,322 funds tracked by Wall St. Rank held Amgen as of Q3 2022.

Based on Ativo Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.